Top

Journal of Neurology

Published in:

01-05-2019 | Magnetic Resonance Imaging | Letter to the Editors

Defining metronidazole-induced encephalopathy

Authors: Akira Kuriyama, Jeffrey L. Jackson

Published in: Journal of Neurology | Issue 5/2019

Excerpt

Dear Sirs, …

Sorensen CG, Karlsson WK, Amin FM, Lindelof M (2018) Metronidazole-induced encephalopathy: a systematic review. J Neurol. https://doi.org/10.1007/s00415-018-9147-6 CrossRefPubMed

Kuriyama A, Jackson JL, Doi A, Kamiya T (2011) Metronidazole-induced central nervous system toxicity: a systematic review. Clin Neuropharmacol 34(6):241–247. https://doi.org/10.1097/WNF.0b013e3182334b35 CrossRefPubMed

Rohatgi A, Monga R, Goyal D (2000) Metronidazole induced acute confusional agitated state. J Assoc Phys India 48(2):261

Bhattacharyya S, Darby R, Berkowitz AL (2014) Antibiotic-induced neurotoxicity. Curr Infect Dis Rep 16(12):448. https://doi.org/10.1007/s11908-014-0448-3 CrossRefPubMed

Bhattacharyya S, Darby RR, Raibagkar P, Gonzalez Castro LN, Berkowitz AL (2016) Antibiotic-associated encephalopathy. Neurology 86(10):963–971. https://doi.org/10.1212/WNL.0000000000002455 CrossRefPubMed

Biancone L, Annese V, Ardizzone S, Armuzzi A, Calabrese E, Caprioli F, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D’Inca R, Frieri G, Fries W, Gionchetti P, Kohn A, Latella G, Milla M, Orlando A, Papi C, Petruzziello C, Riegler G, Rizzello F, Saibeni S, Scribano ML, Vecchi M, Vernia P, Meucci G, Italian Group for the Study of Inflammatory Bowel D (2017) Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Digest Liver Dis 49(4):338–358. https://doi.org/10.1016/j.dld.2017.01.141 CrossRef

Cornely OA, Nathwani D, Ivanescu C, Odufowora-Sita O, Retsa P, Odeyemi IA (2014) Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison. J Antimicrob Chemother 69(11):2892–2900. https://doi.org/10.1093/jac/dku261 CrossRefPubMed

Daniels LM, Kufel WD (2018) Clinical review of Clostridium difficile infection: an update on treatment and prevention. Expert Opin Pharmacother 19(16):1759–1769. https://doi.org/10.1080/14656566.2018.1524872 CrossRefPubMed

Goolsby TA, Jakeman B, Gaynes RP (2018) Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature. Int J Antimicrob Agents 51(3):319–325. https://doi.org/10.1016/j.ijantimicag.2017.08.033 CrossRefPubMed

10.

Leong C, Zelenitsky S (2013) Treatment strategies for recurrent clostridium difficile infection. Can J Hosp Pharm 66(6):361–368PubMedPubMedCentral

11.

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH (2018) Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66(7):e1–e48. https://doi.org/10.1093/cid/cix1085 CrossRefPubMedPubMedCentral

12.

Ooijevaar RE, van Beurden YH, Terveer EM, Goorhuis A, Bauer MP, Keller JJ, Mulder CJJ, Kuijper EJ (2018) Update of treatment algorithms for Clostridium difficile infection. Clin Microbiol Infect 24 (5):452–462. https://doi.org/10.1016/j.cmi.2017.12.022 CrossRefPubMed

13.

Chai J, Lee CH (2018) Management of primary and recurrent clostridium difficile infection: an update. Antibiotics (Basel Switzerland). https://doi.org/10.3390/antibiotics7030054 CrossRef

14.

Zutshi D (2017) Medication-induced seizures and status epilepticus. In: Husain A, Sinha S (eds) Continuous EEG monitoring: principles and practice. Springer, New York, pp 361–382CrossRef

15.

Sarna JR, Furtado S, Brownell AK (2013) Neurologic complications of metronidazole. Can J Neurol Sci 40(6):768–776CrossRefPubMed

Title: Defining metronidazole-induced encephalopathy
Authors: Akira Kuriyama
Jeffrey L. Jackson
Publication date: 01-05-2019
Publisher: Springer Berlin Heidelberg
Keywords: Magnetic Resonance Imaging
Magnetic Resonance Imaging
Metronidazole
Polyneuropathy
Encephalopathy
Published in: Journal of Neurology / Issue 5/2019
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-019-09275-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Defining metronidazole-induced encephalopathy

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2019

Resolution of apathy after dorsal instead of ventral subthalamic deep brain stimulation for Parkinson’s disease

Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)

Autoimmune encephalitis: frequency and prognosis

Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA

Neurological update: MOG antibody disease

Blood pressure circadian rhythm alterations in alpha-synucleinopathies